Arkolith/Insider Trading/NBRV/Form 4

Schroeder Theodore R

Chief Executive Officer, DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Dec 29, 2021
Net Buying
Open-Market Buys
$57K
Open-Market Sells
$0
Net Open-Market Flow
$57K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Buy(P)100K$0.57$57K326K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-154397) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML